A Study of Mircera in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis

NCT00081471 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

324

Enrollment

INDUSTRY

Sponsor class

Conditions

Anemia

Interventions

DRUG: darbepoetin alfa
DRUG: methoxy polyethylene glycol-epoetin beta [Mircera]

Sponsor

Hoffmann-La Roche